Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Dosing in Children with Acute Pain
NCT05641363Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jun 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in acute pain (3 arms), sponsored by Hamilton Health Sciences. Primary endpoint: Pain relief measured by VNRS at 60 months. Started Jun 2023; status: completed.
02
Drugs
ketorolac
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05641363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641363.